BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35488235)

  • 1. Preoperative risk factors of lymph node metastasis in clinical N0 lung adenocarcinoma of 3 cm or less in diameter.
    Fang C; Xiang Y; Han W
    BMC Surg; 2022 Apr; 22(1):153. PubMed ID: 35488235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node metastasis risk factors in clinical stage IA3 lung adenocarcinoma.
    Zheng Y; Ju S; Huang R; Zhao J
    J Cancer Res Ther; 2023 Feb; 19(1):34-38. PubMed ID: 37006040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors for Occult Lymph Node Metastasis in Peripheral Non-Small Cell Lung Cancer with Invasive Component Size 3 cm or Less.
    Moon Y; Choi SY; Park JK; Lee KY
    World J Surg; 2020 May; 44(5):1658-1665. PubMed ID: 31912252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for lymph node metastasis and surgical methods in patients with early-stage peripheral lung adenocarcinoma presenting as ground glass opacity.
    Wang Y; Jing L; Wang G
    J Cardiothorac Surg; 2020 Aug; 15(1):121. PubMed ID: 32782020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
    Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective study of the relationship between the pathologic subtype and lymph node metastasis of lung adenocarcinomas of ≤3 cm diameter.
    Lin W; Huang M; Zhang Z; Chai T; Chen S; Gao L; Lin J; Kang M
    Medicine (Baltimore); 2020 Sep; 99(36):e21453. PubMed ID: 32898994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Predicting Occult Lymph Node Metastasis in Patients with Clinical Stage I Non-small Cell Lung Cancer Staged by Integrated Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Kaseda K; Asakura K; Kazama A; Ozawa Y
    World J Surg; 2016 Dec; 40(12):2976-2983. PubMed ID: 27456499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Texture Analysis-Based Prediction Model for Lymph Node Metastasis in Stage IA Lung Adenocarcinoma.
    Gu Y; She Y; Xie D; Dai C; Ren Y; Fan Z; Zhu H; Sun X; Xie H; Jiang G; Chen C
    Ann Thorac Surg; 2018 Jul; 106(1):214-220. PubMed ID: 29550204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node metastasis and its risk factors in T1 lung adenocarcinoma.
    Zhang W; Mu G; Huang J; Bian C; Wang H; Gu Y; Xia Y; Chen L; Yuan M; Wang J
    Thorac Cancer; 2023 Oct; 14(30):2993-3000. PubMed ID: 37667435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.
    Inoue M; Minami M; Shiono H; Sawabata N; Ideguchi K; Okumura M
    J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Potential value of FDG PET-CT in predicting occult lymph node metastasis in clinical stage ⅠA lung adenocarcinoma].
    Lyu L; Liu Y; Wang XY; Zhang ZK; Tao XL; Yang L; Wu N
    Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):441-447. PubMed ID: 31216830
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors that predict lymph node status in clinical stage T1aN0M0 lung adenocarcinomas.
    Ye B; Cheng M; Ge XX; Geng JF; Li W; Feng J; Hu DZ; Zhao H
    World J Surg Oncol; 2014 Feb; 12():42. PubMed ID: 24559138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation factors of lymph node metastasis in patients with clinical stage T1a non-small cell lung cancer].
    Ruochuan Z; Shugeng G; Jie H; Yousheng M; Qi X; Dali W; Juwei M; Jun Z; Yonggang W; Xiangyang L; Fengwei T; Gefei Z; Qian Z; Moyan Z; Peng S
    Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):297-300. PubMed ID: 26462896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation analysis between imaging features and lymph node metastasis in T1a lung adenocarcinoma].
    Ye B; Feng J; Pan XF; Yang Y; Geng JF; Cao KJ; Zhao H; Hu DZ
    Zhonghua Wai Ke Za Zhi; 2013 Oct; 51(10):904-7. PubMed ID: 24433769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes and predictive factors for pathological node-positive in radiographically pure-solid, small-sized lung adenocarcinoma.
    Kayata H; Isaka M; Terada Y; Mizuno K; Yasuura Y; Kojima H; Ohde Y
    Gen Thorac Cardiovasc Surg; 2019 Jun; 67(6):544-550. PubMed ID: 30627979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non-small-cell lung cancer patients.
    Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
    J Thorac Oncol; 2012 Aug; 7(8):1246-51. PubMed ID: 22659962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult mediastinal lymph node metastasis in FDG-PET/CT node-negative lung adenocarcinoma patients: Risk factors and histopathological study.
    Miao H; Shaolei L; Nan L; Yumei L; Shanyuan Z; Fangliang L; Yue Y
    Thorac Cancer; 2019 Jun; 10(6):1453-1460. PubMed ID: 31127706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prediction model for lymph node metastases using pathologic features in patients intraoperatively diagnosed as stage I non-small cell lung cancer.
    Zhao F; Zhou Y; Ge PF; Huang CJ; Yu Y; Li J; Sun YG; Meng YC; Xu JX; Jiang T; Zhang ZX; Sun JP; Wang W
    BMC Cancer; 2017 Apr; 17(1):267. PubMed ID: 28407802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk Factors and Sampling Range Evaluation of Lymph node Metastasis for 
Non-small Cell Lung Cancer with Diameter ≤2 cm].
    Jin T; He Z; Li Z; Tang J; Xu J; Wu W; Chen L
    Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):507-514. PubMed ID: 37653014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lobe-Specific Lymph Node Dissection May be Feasible for Clinical N0 Solid-Predominant Part-Solid Lung Adenocarcinoma With Solid Component Diameter ≤ 2 cm.
    Wo Y; Li H; Chen Z; Peng Y; Zhang Y; Ye T; Jiang W; Sun Y
    Clin Lung Cancer; 2023 Jul; 24(5):437-444. PubMed ID: 37029008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.